Beneficial Stats

Statisticians who normally crunch numbers to forecast trends in the food-service industry turn their attention to bettering treatment of ALS.

Written byAimee Swartz
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

PUZZLE MASTERS: The network of researchers that participate in DREAM-sponsored challenges provide pieces of the solution to important biomedical problems. Problems range from very basic science questions such as the inference of biological networks, to translational problems, such as models for disease prognosis and treatment response. To date DREAM has curated 32 open challenges. DANIEL MARBACH AND VALDO PEIXOTO

Statistician Liuxia Wang is in the business of prediction. At Sentrana Inc., a Washington, D.C.-based sales and marketing company, she uses data on consumers’ spending behaviors to forecast future trends in the food-service industry. But she never imagined her analytical expertise could be put to use helping patients suffering from amyotrophic lateral sclerosis (ALS), the fatal neurodegenerative disease commonly known as Lou Gehrig’s disease.

“At the end of the day, data is data, whether you’re using it to find the optimal price for certain products or estimating a disease’s course,” says Wang. “But it’s nice to be able to use predictive analytics to benefit patients.”

Working under the team name “Sentrana,” Wang and her colleague Guang “Eric” Li, a quantitative modeler, beat a global community ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies